ESR1 and triple-negative breast carcinoma: We utilized the highly invasive MDA-MB-231, a cell line that is negative for the estrogen receptor (ER-), HER2 receptor and progesteron receptor (PR), thereby serving as an in vitro model of triple-negative breast cancer.